|
Volumn 47, Issue 6, 1997, Pages 734-745
|
Pharmacokinetics of miglitol: Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man;Pharmakokinetik von Miglitol/Resorption, Verteilung, Metabolismus und Ausscheidung nach Verabreichung an Ratten, Hunde und Menschen
|
Author keywords
Antidiabetic drug; BAY m 1099, different species, metabolism , pharmacokinetics; CAS 72432 03 2; Glucosidase inhibitor; Miglitol
|
Indexed keywords
CARBON 14;
MIGLITOL;
TRITIUM;
ANIMAL TISSUE;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOG;
DOSE RESPONSE;
DRUG ABSORPTION;
DRUG DISTRIBUTION;
DRUG EXCRETION;
DRUG METABOLISM;
FEMALE;
HUMAN;
INTRADUODENAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PHARMACOKINETICS;
RADIOACTIVITY;
RAT;
ADMINISTRATION, ORAL;
ALPHA-GLUCOSIDASES;
ANIMALS;
AUTORADIOGRAPHY;
BLOOD PROTEINS;
DOGS;
DUODENUM;
ENZYME INHIBITORS;
FECES;
FEMALE;
GLUCOSAMINE;
HUMANS;
IMINO PYRANOSES;
INJECTIONS, INTRAVENOUS;
MALE;
MILK;
PLACENTA;
PREGNANCY;
PROTEIN BINDING;
RATS;
RATS, SPRAGUE-DAWLEY;
RATS, WISTAR;
SPECIES SPECIFICITY;
TISSUE DISTRIBUTION;
|
EID: 0030832427
PISSN: 00044172
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (90)
|
References (8)
|